Treatment-resistant major depressive disorder and assisted dying
Other content recommended for you
- Choosing death in depression: a commentary on ‘Treatment-resistant major depressive disorder and assisted dying’
- Esketamine for treatment-resistant depression
- Treatment-resistant depression and physician-assisted death
- Physician-assisted dying and two senses of an incurable condition
- New use for an old drug: oral ketamine for treatment-resistant depression
- Drawing the line on physician-assisted death
- Externalist argument against medical assistance in dying for psychiatric illness
- Treatment-resistant major depressive disorder and assisted dying: response to comments
- Non-physician-assisted suicide in The Netherlands: a cross-sectional survey among the general public
- Commentary on ‘Treatment-resistant major depressive disorder and assisted dying’
Jump to comment:
Schuklenk and van der Vathorst's feature paper articulates powerful and persuasive arguments to the effect that denying patients with treatment-resistant depression (TRD) assistance in dying results in unnecessary suffering and amounts to unfair discrimination against TRD patients.
Beyond TRD, the same arguments can readily (and in my view appropriately) be used to support assisted dying...
Dear Editor. I do occasional psychiatric assessments for people contemplating medically-assisted rational suicide (MARS) in Switzerland and broadly agree with Schuklenk and van der Vathorst's arguments. Usually, my role is limited to assessing mental capacity and excluding the existence of a treatable psychiatric condition that might be influencing the patient's decision to include MARS in the list of acceptable options....